Healthcare provider profile · identity verified

Patrick Jahn, NP

Nurse Practitioner · THIEF RIVER FALLS, MN · NPI 1437406907

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	401	120
Lisinopril	Lisinopril	332	93
Rosuvastatin Calcium	Rosuvastatin Calcium	303	95
Omeprazole	Omeprazole	264	88
Levothyroxine Sodium	Levothyroxine Sodium	256	92
Metoprolol Succinate	Metoprolol Succinate	252	76
Simvastatin	Simvastatin	250	74
Tamsulosin Hcl	Tamsulosin Hcl	234	61
Amlodipine Besylate	Amlodipine Besylate	224	70
Losartan Potassium	Losartan Potassium	213	65
Hydrochlorothiazide	Hydrochlorothiazide	188	56
Metformin Hcl	Metformin Hcl	179	55
Furosemide	Furosemide	124	37
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	118	38
Gabapentin	Gabapentin	104	35
Pantoprazole Sodium	Pantoprazole Sodium	97	35
Finasteride	Finasteride	88	28
Metoprolol Tartrate	Metoprolol Tartrate	87	32
Allopurinol	Allopurinol	85	24
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	82	21
Triamcinolone Acetonide	Triamcinolone Acetonide	77	46
Glipizide Er	Glipizide	76	18
Montelukast Sodium	Montelukast Sodium	74	27
Fluticasone Propionate	Fluticasone Propionate	72	24
Clopidogrel	Clopidogrel Bisulfate	71	17
Tramadol Hcl	Tramadol Hcl	69	26
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	66	20
Pravastatin Sodium	Pravastatin Sodium	62	23
Eliquis	Apixaban	61	14
Sertraline Hcl	Sertraline Hcl	61	22
Carvedilol	Carvedilol	56	17
Atenolol	Atenolol	52	14
Metformin Hcl Er	Metformin Hcl	52	16
Jantoven	Warfarin Sodium	50	17
Zolpidem Tartrate	Zolpidem Tartrate	50	15
Potassium Chloride	Potassium Chloride	49	18
Albuterol Sulfate Hfa	Albuterol Sulfate	47	22
Ozempic	Semaglutide	47	16
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	46	15
Alprazolam	Alprazolam	45	20
Baclofen	Baclofen	44	suppressed
Duloxetine Hcl	Duloxetine Hcl	44	11
Glipizide	Glipizide	42	suppressed
Memantine Hcl	Memantine Hcl	39	suppressed
Warfarin Sodium	Warfarin Sodium	39	19
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	38	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	36	suppressed
Trazodone Hcl	Trazodone Hcl	34	15
Levetiracetam	Levetiracetam	33	suppressed
Ezetimibe	Ezetimibe	32	12
Betamethasone Dipropionate	Betamethasone Dipropionate	31	19
Fluoxetine Hcl	Fluoxetine Hcl	31	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	31	11
Xarelto	Rivaroxaban	31	suppressed
Citalopram Hbr	Citalopram Hydrobromide	30	suppressed
Donepezil Hcl	Donepezil Hcl	30	11
Famotidine	Famotidine	30	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	30	suppressed
Mirtazapine	Mirtazapine	29	suppressed
Prednisone	Prednisone	29	14
Ropinirole Hcl	Ropinirole Hcl	29	suppressed
Spironolactone	Spironolactone	29	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	27	suppressed
Divalproex Sodium	Divalproex Sodium	27	suppressed
Metronidazole	Metronidazole	27	17
Meloxicam	Meloxicam	26	11
Potassium Citrate Er	Potassium Citrate	26	suppressed
Paroxetine Hcl	Paroxetine Hcl	25	suppressed
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	24	suppressed
Valsartan	Valsartan	24	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	24	suppressed
Humalog Kwikpen U-100	Insulin Lispro	23	suppressed
Jardiance	Empagliflozin	23	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	22	suppressed
Ventolin Hfa	Albuterol Sulfate	22	13
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	21	suppressed
Clobetasol Propionate	Clobetasol Propionate	21	13
Gemfibrozil	Gemfibrozil	21	suppressed
Hydralazine Hcl	Hydralazine Hcl	21	suppressed
Klor-Con M20	Potassium Chloride	21	suppressed
Methotrexate	Methotrexate Sodium	21	suppressed
Oxycodone Hcl	Oxycodone Hcl	21	suppressed
Trimethoprim	Trimethoprim	21	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	20	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	20	suppressed
Nystatin	Nystatin	19	12
Clonazepam	Clonazepam	18	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	18	11
Escitalopram Oxalate	Escitalopram Oxalate	18	suppressed
Lovastatin	Lovastatin	18	suppressed
Fluorouracil	Fluorouracil	17	17
Terazosin Hcl	Terazosin Hcl	17	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	16	suppressed
Nitroglycerin	Nitroglycerin	16	11
Bumetanide	Bumetanide	15	suppressed
Hydrocortisone	Hydrocortisone	15	12
Lorazepam	Lorazepam	15	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	15	suppressed
Spiriva Handihaler	Tiotropium Bromide	15	suppressed
Trulicity	Dulaglutide	15	suppressed
Carisoprodol	Carisoprodol	14	suppressed
Clonidine Hcl	Clonidine Hcl	14	suppressed
Ketoconazole	Ketoconazole	14	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	14	suppressed
Breo Ellipta	Fluticasone/Vilanterol	13	suppressed
Ciclopirox	Ciclopirox Olamine	13	suppressed
Fentanyl	Fentanyl	13	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	13	suppressed
Ondansetron Odt	Ondansetron	13	suppressed
Sucralfate	Sucralfate	13	suppressed
Taltz Autoinjector	Ixekizumab	13	suppressed
Fluticasone Propionate Hfa	Fluticasone Propionate	12	suppressed
Sotalol	Sotalol Hcl	12	suppressed
Buspirone Hcl	Buspirone Hcl	11	suppressed
Dupixent Syringe	Dupilumab	11	suppressed
Dutasteride	Dutasteride	11	suppressed
Klor-Con M10	Potassium Chloride	11	suppressed
Propranolol Hcl	Propranolol Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error